Saturday, July 11, 2026

Drug profile · INN

sodium phosphate p-32

sodium phosphate p-32 (SODIUM PHOSPHATE P 32) is a radiopharmaceutical. Route of administration: injection, oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — sodium phosphate p-32
US status
approved
Class
Route
INJECTION, ORAL
Patents
0
Programs
0
Data quality
0.84

Quick answer

sodium phosphate p-32 (SODIUM PHOSPHATE P 32) is a radiopharmaceutical. Route of administration: injection, oral. Current US regulatory status: approved.

Key facts

INN sodium phosphate p-32
Brand SODIUM PHOSPHATE P 32
Mechanism Radiopharmaceutical
Route INJECTION, ORAL
Formulation SOLUTION

Mechanism of action

Radiopharmaceutical

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is sodium phosphate p-32?

sodium phosphate p-32 (SODIUM PHOSPHATE P 32) is a radiopharmaceutical. Route of administration: injection, oral. Current US regulatory status: approved.

What is the brand name for sodium phosphate p-32?

SODIUM PHOSPHATE P 32 is a marketed brand name for sodium phosphate p-32. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sodium phosphate p-32?

sodium phosphate p-32 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.